Tag: Sanofi
Sanofi India & Emcure Pharma announce exclusive distribution partnership to broaden...
While SIL will continue to own, import, and manufacture these brands across Sanofi’s plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Medidata & Sanofi Vaccines extend collaboration to improve patient centricity &...
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real time data capture
Sanofi India’s Type 1 Diabetes Social Impact Program with RSSDI delivering...
Improved access to care and management resulting in fewer episodes of hypoglycaemia and hyperglycaemia per week
Sanofi India registers 12% growth in operating profits in Q2 of...
The Company was largely able to maintain its gross margins, despite the NLEM impact
Sanofi’s biologic ‘Dupixent’ to treat atopic dermatitis gets approval in India
It is the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
Sanofi reaffirms commitment to rare diseases in India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Sanofi India appoints Rodolfo Hrosz as its new Managing Director
Hrosz will transition from being Sanofi’s General Manager, Consumer Healthcare business in Brazil to his new role in India as soon as the applicable regulatory approvals are in place
Sanofi & GSK to seek USFDA & EMA approval for Covid-19...
When used as a two-dose primary series, the Sanofi-GSK vaccine delivered robust levels of neutralizing antibodies, with GMTs reaching 3711 units
Sanofi India appoints Vaibhav Karandikar as Chief Financial Officer
Vaibhav Karandikar has been appointed as the Chief Financial Officer of Sanofi India Limited on 6th October 2020......................
Sanofi Genzyme observes Rare Disease Day in India
The company said that it stands committed to the cause of supporting patients with rare and debilitating disorders............